Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activity.
Metheny L, Eid S, Wuttisarnwattana P, Auletta JJ, Liu C, Van Dervort A, Paez C, Lee Z, Wilson D, Lazarus HM, Deans R, Vant Hof W, Ktena Y, Cooke KR.
Metheny L, et al. Among authors: lazarus hm.
Stem Cells. 2021 Nov;39(11):1506-1519. doi: 10.1002/stem.3434. Epub 2021 Jul 28.
Stem Cells. 2021.
PMID: 34255899
Free PMC article.